Outlook Therapeutics Inc
XNAS: OTLK
Outlook Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an oph...
Read More
0.97
0.01
(1.04%)
1.2M
XNAS Volume
XNAS 22 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Outlook Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..